Nuvectis Pharma, Inc. (NVCT) SEC Filings — 2025
12 SEC filings for Nuvectis Pharma, Inc. (NVCT) in 2025.
Filings
- Nuvectis Pharma's Losses Widen Amid Soaring R&D Costs — 10-Q · Nov 4, 2025
- Nuvectis Pharma Reports Director Changes and Officer Compensation Adjustments — 8-K · Sep 25, 2025
- Nuvectis Pharma Files 8-K on Financials — 8-K · Aug 5, 2025
- Nuvectis Pharma's Q2 Loss Widens Amidst Capital Raises — 10-Q · Aug 5, 2025
- Nuvectis Pharma Files 8-K on Shareholder Votes — 8-K · Jun 13, 2025
- Nuvectis Pharma Files 8-K — 8-K · May 9, 2025
- Nuvectis Pharma Files 8-K on Operations and Financials — 8-K · May 6, 2025
- Nuvectis Pharma Q1 2025: No Revenue, Focus on Capital — 10-Q · May 6, 2025
- Nuvectis Pharma Files Definitive Proxy Statement — DEF 14A · Apr 28, 2025
- Nuvectis Pharma Files 8-K on Financials — 8-K · Feb 25, 2025
- Nuvectis Pharma Files 2024 10-K, Details Financials — 10-K · Feb 25, 2025
- Nuvectis Pharma Files 8-K for Material Agreement — 8-K · Feb 6, 2025